Developing a Cell-Based Matrix Approach for AAV Gene Therapy

Time: 9:30 am
day: Day 1

Details:

  • Understanding the variability of TCID50
  • Optimizing a function potency assay: challenges and lessons learned
  • Incorporating a protein expression assay into a potency strategy during product development

Speakers: